SoylentNews is people
SoylentNews
Questionable herpes vaccine research backed by tech heavyweight Peter Thiel may have jeopardized $15 million in federal research funding to Southern Illinois University School of Medicine. That's according to documents obtained by a Freedom of Information Act request by The State Journal Register.
In August, Kaiser Health News reported that Thiel and other conservative investors had contributed $7 million for the live-but-weakened herpes virus vaccine, developed by the late SIU researcher William Halford. The investments came after Halford and his private company, Rational Vaccines, had begun conducting small clinical trials in the Caribbean nation of St. Kitts and Nevis. With the off-shore location, Rational Vaccines' trial skirted federal regulations and standard safety protocols for human trials, including having approval and oversight from an institutional review board (IRB).
Experts were quick to call the unapproved trial "patently unethical," and researchers rejected the data from publication, calling the handling of safety issues "reckless." The government of St. Kitts opened an investigation into the trial and reported that health authorities there had been kept in the dark.
(Score: 2, Insightful) by Anonymous Coward on Thursday November 16 2017, @06:34PM (1 child)
That issue you mention is exactly why it can't generally be allowed. Unsafe experimental treatments should be extreme outliers with lots of scrutiny, otherwise we'll see people doing their research in backwater villages where scientific education is zilch and it is easy to convince sick people that the treatment is their only chance of living. Any such unsafe treatments should have the explanations and agreement recorded so that it is clear the patient understands the risks.
(Score: 2) by takyon on Thursday November 16 2017, @07:16PM
Treatments don't become widely used after a single human trial on some Caribbean island.
Well, maybe that is set to change.
[SIG] 10/28/2017: Soylent Upgrade v14 [soylentnews.org]